Suppr超能文献

脑结构剂量与接受 SJMB03 治疗的髓母细胞瘤患儿认知结局的相关性:迈向基于结构的计划。

Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.

机构信息

Department of Radiation Oncology, St Jude Children's Research Hospital, Memphis, TN.

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine, Baltimore, MD.

出版信息

J Clin Oncol. 2022 Jan 1;40(1):83-95. doi: 10.1200/JCO.21.01480. Epub 2021 Oct 29.

Abstract

PURPOSE

To characterize the association between neurocognitive outcomes (memory and processing speed) and radiation (RT) dose to the hippocampus, corpus callosum (CC), and frontal white matter (WM) in children with medulloblastoma treated on a prospective study, SJMB03.

PATIENTS AND METHODS

Patients age 3-21 years with medulloblastoma were treated at a single institution on a phase III study. The craniospinal RT dose was 23.4 Gy for average-risk patients and 36-39.6 Gy for high-risk patients. The boost dose was 55.8 Gy to the tumor bed. Patients underwent cognitive testing at baseline and once yearly for 5 years. Performance on tests of memory (associative memory and working memory) and processing speed (composite processing speed and perceptual speed) was analyzed. Mixed-effects models were used to estimate longitudinal trends in neurocognitive outcomes. Reliable change index and logistic regression were used to define clinically meaningful neurocognitive decline and identify variables associated with decline.

RESULTS

One hundred and twenty-four patients were eligible for inclusion, with a median neurocognitive follow-up of 5 years. Mean right and left hippocampal doses were significantly associated with decline in associative memory in patients without posterior fossa syndrome (all < .05). Mean CC and frontal WM doses were significantly associated with decline in both measures of processing speed (all < .05). Median brain substructure dose-volume histograms were shifted to the right for patients with a decline in associative memory or processing speed. The odds of decline in associative memory and composite processing speed increased by 23%-26% and by 10%-15% for every 1-Gy increase in mean hippocampal dose and mean CC or frontal WM dose, respectively.

CONCLUSION

Increasing RT dose to the CC or frontal WM and hippocampus is associated with worse performance on tests of processing speed and associative memory, respectively. Brain substructure-informed RT planning may mitigate neurocognitive impairment.

摘要

目的

描述神经认知结果(记忆和处理速度)与接受前瞻性研究(SJMB03)治疗的髓母细胞瘤患儿海马体、胼胝体(CC)和额白质(WM)的放射治疗(RT)剂量之间的关系。

方法

在一个单机构的 III 期研究中,对年龄在 3-21 岁的髓母细胞瘤患者进行治疗。平均风险患者的颅脊髓 RT 剂量为 23.4Gy,高危患者为 36-39.6Gy。肿瘤床给予 55.8Gy 的剂量增强。患者在基线和每年一次接受认知测试,共进行 5 年。分析了记忆(联想记忆和工作记忆)和处理速度(综合处理速度和知觉速度)测试的表现。采用混合效应模型估计神经认知结果的纵向趋势。可靠变化指数和逻辑回归用于定义有临床意义的神经认知下降,并确定与下降相关的变量。

结果

共有 124 名患者符合纳入标准,神经认知随访中位数为 5 年。在没有后颅窝综合征的患者中,右和左海马体的平均剂量与联想记忆的下降显著相关(均 <.05)。CC 和额 WM 的平均剂量与两种处理速度测量值的下降均显著相关(均 <.05)。对于联想记忆或处理速度下降的患者,中位数脑亚结构剂量-体积直方图向右移位。平均海马体剂量和 CC 或额 WM 剂量每增加 1Gy,联想记忆和综合处理速度下降的几率分别增加 23%-26%和 10%-15%。

结论

CC 或额 WM 和海马体的 RT 剂量增加与处理速度和联想记忆测试的表现下降相关。基于脑亚结构的 RT 计划可能减轻神经认知损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7b/8683226/c35bcaffc2a1/jco-40-83-g003.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验